Skip to main content
SpringerLink
Log in

Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross-sectional study from a single center in China

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

To explore the spectrum, clinicopathological features and prognosis of patients with inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC) with renal involvement. Included in this cross-sectional study were 36 IBD patients, in whom renal biopsy was performed to analyze the histological pattern and prognosis. Renal histopathology was examined by light microscopy and immunofluorescence using the standard procedures. Renal function decline was defined as a twofold increase in serum creatinine (SCr) after biopsy, initiation of dialysis and transplantation. Of the 36 IBD patients (22 UC and 14 CD), renal biopsy was performed in 33 cases. Compared with UC patients, CD patients were significantly younger at presentation and had a higher proportion of chronic renal insufficiency (CRI). The most common renal histological pattern in the 33 biopsy cases was IgA nephropathy (66.6%), followed by membrane nephropathy (9.1%), amyloidosis (9.1%), tubulointerstitial nephritis (9.1%), and membranoproliferative glomerulonephritis (6.1%). Renal function decline occurred in 4 patients (1 with amyloidosis, 1 with TIN and 2 with CRI). Factors associated with renal function decline included CD and a higher SCr level at presentation. Urinalysis and renal function test should be routinely examined in IBD patients. Renal biopsy can provide useful information about the histological patterns and therefore should be considered in IBD patients with renal lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–7.

    Article  Google Scholar 

  2. Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94(1):155–65.

    Article  CAS  Google Scholar 

  3. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390(10114):2769–78.

    Article  Google Scholar 

  4. Ng SC, Kaplan GG, Tang W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 Countries or regions in Asia-Pacific. Am J Gastroenterol. 2019;114(1):107–15.

    Article  Google Scholar 

  5. Ott C, Scholmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10(10):585–95.

    Article  CAS  Google Scholar 

  6. Corica D, Romano C. Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 2016;10(2):226–35.

    Article  Google Scholar 

  7. Isene R, Bernklev T, Hoie O, et al. Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol. 2015;50(3):300–5.

    Article  Google Scholar 

  8. Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol. 2014;9(2):265–70.

    Article  Google Scholar 

  9. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43(1):29–32.

    Article  CAS  Google Scholar 

  10. Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;1(8167):514.

    Article  CAS  Google Scholar 

  11. Yang Y, Zhang Z, Zhuo L, Chen DP, Li WG. The spectrum of biopsy-proven glomerular disease in China: a systematic review. Chin Med J (Engl). 2018;131(6):731–5.

    Article  Google Scholar 

  12. Coppo R. The gut-renal connection in IgA NEPHROPATHY. Semin Nephrol. 2018;38(5):504–12.

    Article  CAS  Google Scholar 

  13. Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: Causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573–84.

    Article  Google Scholar 

  14. Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20(8):970–9.

    Article  CAS  Google Scholar 

  15. Sattianayagam PT, Gillmore JD, Pinney JH, et al. Inflammatory bowel disease and systemic AA amyloidosis. Dig Dis Sci. 2013;58(6):1689–97.

    Article  CAS  Google Scholar 

  16. Tosca Cuquerella J, Bosca-Watts MM, Anton Ausejo R, Tejedor Alonso S, Mora De Miguel F, Minguez Perez M. Amyloidosis in inflammatory bowel disease: a systematic review of epidemiology, clinical features, and treatment. J Crohns Colitis. 2016;10(10):1245–53.

    Article  Google Scholar 

  17. Ryšavá R. AL amyloidosis: advances in diagnostics and treatment. Nephrol Dial Transplant. 2019;34(9):1460–6.

    Article  CAS  Google Scholar 

  18. Saha MK, Tarek H, Sagar V, Abraham P. Role of tumor necrosis factor inhibitor in granulomatous interstitial nephritis secondary to Crohn’s disease. Int Urol Nephrol. 2014;46(1):229–33.

    Article  Google Scholar 

  19. Durando M, Tiu H, Kim JS. Sulfasalazine-induced crystalluria causing severe acute kidney injury. Am J Kidney Dis. 2017;70(6):869–73.

    Article  CAS  Google Scholar 

  20. Troxell ML, Higgins JP, Kambham N. Antineoplastic treatment and renal injury: an update on renal pathology due to cytotoxic and targeted therapies. Adv Anat Pathol. 2016;23(5):310–29.

    Article  CAS  Google Scholar 

  21. Gisbert JP, González-Lama Y, Maté J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2007;13(5):629–38.

    Article  Google Scholar 

  22. Waters AM, Zachos M, Herzenberg AM, Harvey E, Rosenblum ND. Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn’s disease. Nat Clin Pract Nephrol. 2008;4(12):693–7.

    Article  Google Scholar 

  23. Izzedine H, Simon J, Piette AM, et al. Primary chronic interstitial nephritis in Crohn’s disease. Gastroenterology. 2002;123(5):1436–40.

    Article  Google Scholar 

  24. Heap GA, So K, Weedon M, et al. Clinical features and HLA Association of 5-Aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease. J Crohns Colitis. 2016;10(2):149–58.

    Article  Google Scholar 

  25. Primas C, Novacek G, Schweiger K, et al. Renal insufficiency in IBD–prevalence and possible pathogenetic aspects. J Crohns Colitis. 2013;7(12):e630-634.

    Article  Google Scholar 

  26. Park S, Chun J, Han KD, et al. Increased end-stage renal disease risk in patients with inflammatory bowel disease: a nationwide population-based study. World J Gastroenterol. 2018;24(42):4798–808.

    Article  Google Scholar 

  27. Vlassara H, Torreggiani M, Post JB, Zheng F, Uribarri J, Striker GE. Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int Suppl. 2009;114:S3-11.

    Article  CAS  Google Scholar 

  28. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton). 2006;11(1):36–41.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Liang Zhao, Guisheng Ren and Rui Fan have contribute equally to this work.

Authors and Affiliations

  1. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

    Liang Zhao, Guisheng Ren, Rui Fan, Xiaopian Feng, Zhengzhao Liu, Zhen Cheng & Ti Zhang

Authors
  1. Liang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guisheng Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rui Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaopian Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhengzhao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhen Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ti Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ti Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, L., Ren, G., Fan, R. et al. Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross-sectional study from a single center in China. Clin Exp Med 22, 629–635 (2022). https://doi.org/10.1007/s10238-021-00766-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-021-00766-0

Keywords

Search

Navigation